Wuxi Biologics (Cayman) Inc. - ADR

Wuxi Biologics (Cayman) Inc. - ADR

WXXWY

Get informed when a big investor buys or sells

+ Follow
Market Cap$26.51B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Wuxi Biologics (Cayman) Inc. - ADRWuxi Biologics (Cayman) Inc. - ADR36.7-17%0.60.1
$-0.20

Current Fair Value

101.6% downside

Overvalued by 101.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$26.51 Billion
Enterprise Value$23.18 Billion
Dividend Yield$- (-)
Earnings per Share$2.38
Beta0.6
Outstanding Shares1,989,859,000

Return

Return on Equity17.38%ROE
Return on Assets12.89%
Return on Invested Capital20.87%

Valuation & Multiples

P/E Ratio36.68P/E Ratio
PEG102.49PEG
Price to Sales0.64Price to Sales
Price to Book Ratio0.49Price to Book Ratio
Enterprise Value to Revenue0.58
Enterprise Value to EBIT2
Enterprise Value to Net Income2
Total Debt to Enterprise0.25
Debt to Equity0.12Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
March 24, 2026
EPS Estimate
$0.18
Average shareholder expectation
Revenue Estimate
$1.71 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 25, 2026
EPS Estimate
$0.13
Average shareholder expectation
Revenue Estimate
$1.70 B
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Wuxi Biologics (Cayman) Inc.

CEO: Zhisheng Chen